OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Immunohistochemical characterisation of the immune landscape in primary uveal melanoma and liver metastases
Pascale Mariani, Nouritza Torossian, Steven Van Laere, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 5, pp. 772-781
Closed Access | Times Cited: 8
Pascale Mariani, Nouritza Torossian, Steven Van Laere, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 5, pp. 772-781
Closed Access | Times Cited: 8
Showing 8 citing articles:
Tebentafusp, a T cell engager, promotes macrophage reprogramming and in combination with IL-2 overcomes macrophage immunosuppression in cancer
Esra Güç, Agatha Treveil, Emma Leach, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Esra Güç, Agatha Treveil, Emma Leach, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Uveal melanoma immunogenomics predict immunotherapy resistance and susceptibility
Shravan Leonard‐Murali, Chetana Bhaskarla, Ghanshyam S. Yadav, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Shravan Leonard‐Murali, Chetana Bhaskarla, Ghanshyam S. Yadav, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Heterogeneity and molecular landscape of melanoma: implications for targeted therapy
Yasaman Zohrab Beigi, Hossein Lanjanian, Reyhane Fayazi, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 10
Yasaman Zohrab Beigi, Hossein Lanjanian, Reyhane Fayazi, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 10
Optimizing TIL therapy for uveal melanoma: lessons learned and unlearned from cutaneous melanoma
Shravan Leonard‐Murali, Udai S. Kammula
Immunotherapy (2025), pp. 1-9
Open Access | Times Cited: 1
Shravan Leonard‐Murali, Udai S. Kammula
Immunotherapy (2025), pp. 1-9
Open Access | Times Cited: 1
Divergent local and systemic antitumor response in primary uveal melanomas
Francesca Lucibello, Ana I. Lalanne, Anne‐Laure Le Gac, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 6
Open Access | Times Cited: 6
Francesca Lucibello, Ana I. Lalanne, Anne‐Laure Le Gac, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 6
Open Access | Times Cited: 6
A Review and Comparison of Immune-Checkpoint Inhibitors in the Treatment of Metastatic Uveal Melanoma
Benyamin Alam, Amir Reza Akbari, Ahmed Ageed, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 885-885
Open Access
Benyamin Alam, Amir Reza Akbari, Ahmed Ageed, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 885-885
Open Access
Transvitreal Retinochoroidal Biopsies of Primary Uveal Melanoma Reveal an Association of Low HLA Class I and High NK Cell Abundance in Low-Risk Disease
Kalijn F. Bol, Mark W. D. Sweep, Michael D. Crowther, et al.
Investigative Ophthalmology & Visual Science (2025) Vol. 66, Iss. 2, pp. 24-24
Open Access
Kalijn F. Bol, Mark W. D. Sweep, Michael D. Crowther, et al.
Investigative Ophthalmology & Visual Science (2025) Vol. 66, Iss. 2, pp. 24-24
Open Access
Tumor infiltrating lymphocytes (TILs) – pathologia, quo vadis? - A global survey
Kristijan Skok, Konstantin Bräutigam
Pathology - Research and Practice (2024) Vol. 266, pp. 155775-155775
Open Access | Times Cited: 1
Kristijan Skok, Konstantin Bräutigam
Pathology - Research and Practice (2024) Vol. 266, pp. 155775-155775
Open Access | Times Cited: 1
